Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Pegvaliase is recommended for treating adults with phenylketonuria.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Burn reconstruction improves with new techniques, materials, and tissue engineering.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.